NO975987L - 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater - Google Patents

4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater

Info

Publication number
NO975987L
NO975987L NO975987A NO975987A NO975987L NO 975987 L NO975987 L NO 975987L NO 975987 A NO975987 A NO 975987A NO 975987 A NO975987 A NO 975987A NO 975987 L NO975987 L NO 975987L
Authority
NO
Norway
Prior art keywords
alkyl
group
radical
cycloalkyl
moiety
Prior art date
Application number
NO975987A
Other languages
English (en)
Other versions
NO975987D0 (no
Inventor
Danielle Gully
Pierre Roger
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of NO975987D0 publication Critical patent/NO975987D0/no
Publication of NO975987L publication Critical patent/NO975987L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Aminotiazolderivater med formel (I), hvorihver av R, og R2 uavhengig er et halogenatom; et C^Cj-hydroksyalkylradikal; CrC5-alkyl; C7-C10-aralkyl; C,-C5-alkoksy; trifluormetyl; nitro; nitril; en gruppe -SR hvor R er hydrogen, et C,-C5-alkylradikal eller et C7-C10-aralkylradikal; en gruppe S-CO-R hvor R er et C,- C5-alkylradikal eller aralkyl, hvori aryldelen er C6-Ce og alkyldelen er CrC«; en gruppe -COOR1 hvor R1 er hydrogen eller C,-C5-alkyl; en gruppe -CONR'R" hvor R' og R" er som definert ovenfor for R1; en gruppe -NR'R" hvor R' og R" er som tidligere definert for R'; en gruppe -CONRaRb eller -NRaRb hvor Ra og Rb, sammen med det nitrogenatom som de er bundet til, danner en 5- til 7-leddet heterocyklisk ring; eller en gruppe -NHCO-NR'R" hvor R' og R" er som definert ovenfor for R'; R3 er hydrogen eller som definert ovenfor for R, og R2; R, er et hydrogenatom; C^Cj-alkyl; halogen; en hydroksymetylgruppe; eller en formyl- gruppe; R5 er C,-C5-alkyl; en C3-C7-cykloalkylgruppe; en cykloalkylalkylgruppe hvori cykloalkyldelen er C3-C7 og alkyldelen er C,-C5; eller C5-C6-alkenyl; n er O eller 1; R6 er C,-C5-alkyl; alkoksyalkyl hvori alkyldelen er CrC5; C3-C7-cykloalkyl; en cykloalkylalkylgruppe hvori cykloalkyldelen er C3-C7 og alkyldelen er C,-C5; et cykloalkyloksyalkylradikal hvori cykloalkyl er C3-C7 og alkyl er C,-C4; et hydroksy- alkyloksyalkylradikal hvori alkyl er C2-C10; eller et alkoksyalkyloksyalkylradikal hvori alkyl er C3-C12; og Z er en eventuelt substituert bi- eller tricyklisk aromatisk eller heteroaromatisk gruppe; og stereoisomerer og/eller addisjonssalter derav.
NO975987A 1995-06-21 1997-12-19 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater NO975987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9507437A FR2735777B1 (fr) 1995-06-21 1995-06-21 Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
PCT/FR1996/000941 WO1997000868A1 (fr) 1995-06-21 1996-06-18 Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
NO975987D0 NO975987D0 (no) 1997-12-19
NO975987L true NO975987L (no) 1998-02-19

Family

ID=9480235

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975987A NO975987L (no) 1995-06-21 1997-12-19 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater

Country Status (22)

Country Link
US (1) US5880135A (no)
EP (1) EP0833822A1 (no)
JP (1) JP3067807B2 (no)
KR (1) KR19990028325A (no)
AU (1) AU710300B2 (no)
BR (1) BR9609420A (no)
CA (1) CA2222266A1 (no)
CZ (1) CZ410397A3 (no)
EE (1) EE9700333A (no)
FR (1) FR2735777B1 (no)
HU (1) HUP9900056A2 (no)
IL (1) IL122293A0 (no)
IS (1) IS4635A (no)
NO (1) NO975987L (no)
NZ (1) NZ312157A (no)
PL (1) PL324202A1 (no)
RU (1) RU2146253C1 (no)
SK (1) SK171197A3 (no)
TR (1) TR199701654T1 (no)
TW (1) TW416952B (no)
WO (1) WO1997000868A1 (no)
ZA (1) ZA965294B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
FR2754258B1 (fr) * 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
US6187777B1 (en) * 1998-02-06 2001-02-13 Amgen Inc. Compounds and methods which modulate feeding behavior and related diseases
PT1129096E (pt) 1998-11-12 2003-09-30 Neurocrine Biosciences Inc Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
WO2000027846A2 (en) 1998-11-12 2000-05-18 Neurocrine Biosciences, Inc. Crf receptor antagonists and methods relating thereto
US6531475B1 (en) 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2796380B3 (fr) 1999-07-15 2001-08-17 Sanofi Synthelabo Nouveaux derives d'aminothiazoles, leur preparation et les compositions pharmaceutiques les contenant
FR2819508B1 (fr) * 2001-01-12 2005-01-21 Sod Conseils Rech Applic Derives de 2-arylimino-2, 3-dihydorthiazoles, leurs procedes de preparation et leur utilisation therapeutiques
US6432989B1 (en) * 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
IL139197A0 (en) 1999-10-29 2001-11-25 Pfizer Prod Inc Use of corticotropin releasing factor antagonists and related compositions
WO2001062718A1 (fr) * 2000-02-25 2001-08-30 Japan Tobacco, Inc. Dérivé de benzamide et utilisation de celui-ci
EP1149583A3 (en) * 2000-04-13 2001-11-14 Pfizer Products Inc. Combinations of corticotropin releasing factor antagonists and growth hormone secretagogues
DE10045650A1 (de) * 2000-09-15 2002-03-28 Adolf Wuerth Gmbh & Co Kg Kunststoffdübel
US7153871B2 (en) * 2001-01-22 2006-12-26 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs
US7205320B2 (en) 2001-01-22 2007-04-17 Memory Pharmaceuticals Corp. Phosphodiesterase 4 inhibitors
EP1423113A4 (en) * 2001-08-13 2007-04-18 Phenex Pharmaceuticals Ag NR1H4 NUCLEAR RECEPTOR BINDING COMPOUNDS
CN100381425C (zh) * 2002-07-19 2008-04-16 记忆药物公司 作为磷酸二酯酶4抑制剂的6-氨基-1h-吲唑及其药物组合物和用途
MXPA05000827A (es) 2002-07-19 2005-08-29 Memory Pharm Corp Inhibidores de fosfodiesterasa 4, incluyendo analogos de anilina y difenilamina n-sustituidos.
CN100513397C (zh) 2002-11-19 2009-07-15 记忆药物公司 磷酸二酯酶4抑制剂
US20090048255A1 (en) * 2003-07-21 2009-02-19 Schumacher Richard A Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs
MY141255A (en) * 2003-12-11 2010-03-31 Memory Pharm Corp Phosphodiesterase 4 inhibitors, including n-substituted diarylamine analogs
ES2389062T3 (es) * 2006-01-18 2012-10-22 Amgen, Inc Compuestos de tiazol como inhibidores de proteína cinasa B (PKB)
US8252333B2 (en) 2006-01-26 2012-08-28 Jorge Cueto-Garcia Biodegradable, non-toxic biological adhesive for use in abdominal surgery
US20100029689A1 (en) * 2008-07-02 2010-02-04 Memory Pharmaceuticals Corporation Phosphodiesterase 4 inhibitors
EP3137454A1 (en) 2014-04-28 2017-03-08 Pfizer Inc. Heteroaromatic compounds and their use as dopamine d1 ligands

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2612187B1 (fr) * 1987-03-12 1989-07-21 Sanofi Sa Derives du thiazole actifs sur le systeme cholinergique, leur procede de preparation et compositions pharmaceutiques en contenant
FR2656610B1 (fr) * 1989-12-29 1992-05-07 Sanofi Sa Derives d'amino-2 phenyl-4 thiazole, leur procede de preparation et leur application therapeutique.
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.

Also Published As

Publication number Publication date
HUP9900056A2 (hu) 1999-05-28
TW416952B (en) 2001-01-01
JPH10511693A (ja) 1998-11-10
IS4635A (is) 1997-12-16
WO1997000868A1 (fr) 1997-01-09
NO975987D0 (no) 1997-12-19
RU2146253C1 (ru) 2000-03-10
AU6362796A (en) 1997-01-22
NZ312157A (en) 1999-04-29
PL324202A1 (en) 1998-05-11
JP3067807B2 (ja) 2000-07-24
MX9710378A (es) 1998-07-31
KR19990028325A (ko) 1999-04-15
FR2735777B1 (fr) 1997-09-12
CZ410397A3 (cs) 1998-04-15
AU710300B2 (en) 1999-09-16
TR199701654T1 (xx) 1998-05-21
ZA965294B (en) 1997-12-22
EE9700333A (et) 1998-06-15
FR2735777A1 (fr) 1996-12-27
CA2222266A1 (fr) 1997-01-09
SK171197A3 (en) 1998-08-05
US5880135A (en) 1999-03-09
IL122293A0 (en) 1998-04-05
EP0833822A1 (fr) 1998-04-08
BR9609420A (pt) 1999-05-18

Similar Documents

Publication Publication Date Title
NO975987L (no) 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater
NO970511L (no) Nye substituerte oksazolidinoner
PT83310A (de) Heterocyclish substitutierte indole zwischenprodukte verfahren zu ihrer herstellung und arzneimittel
EP0040639A4 (en) ISOXAZOLE DERIVATIVES.
NZ532494A (en) Dibenzylamine compound and medicinal use thereof
NO990227L (no) Heterocykliske forbindelser som farmas°ytika
IE891797L (en) 4-amino quinolines and naphthyridines, process for their¹preparation and their use as medicines
HRP20070117T3 (en) Heterocyclic oxime derivatives, process for their preparation and use thereof in the treatment of type ii diabetes
GB1014053A (en) 7-hydroxy-coumarin derivatives and process for their production
ATE19776T1 (de) Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel.
SE7712630L (sv) Forfarande for framstellning av o-alkylerade hydroxylaminer
DK118287D0 (da) Heteroaryloxy-beta-carbolinderivater, deres fremstilling og deres anvendelse som laegemiddel
ES8207526A1 (es) Un procedimiento para la preparacion de nuevos derivados de la quinoleina.
ES466366A1 (es) Un procedimiento para preparar derivados de metasulfonamido-benzamida.
DK393486A (da) Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
IE782028L (en) Substituted furans
ES413043A1 (es) Procedimiento para preparar derivados de rifamicina.
NO941073L (no) Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater
ATE585T1 (de) N-azolylessigsaeureanilide, verfahren zu ihrer herstellung und ihre anwendung als herbizide.
TW350843B (en) 2-(4-pyrazolyloxy-pyrimidin-5-yl) acetic acid derivatives
NO982549L (no) 5-naftalen-1-yl-1,3-dioksan-derivater, fremstilling og terapeutisk anvendelse derav
DE58904677D1 (de) Heterocyclisch substituierte 5,7-dihydro-pyrrolo(3,2-f)benzoxazol-6-one, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel.
EP0798304A4 (en) DRUGS AGAINST TRHOMBOCYTOPENIA
ATE4981T1 (de) Spiro-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
GB2006771A (en) Substituted Heterocyclic Compounds, their Preparation and Pharmaceutical Compositions Containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application